Unrealized Post-Acquisition Synergies and Goodwill Impairment
First written in FY2020. 9 of 12 entries say "Worsened", first in FY2023. Latest entry: FY2026.
The whole theme swung hardest in 2024: 36 of 89 companies on the "Worse" side.
- FY2026WorsenedAnnual report
「Assets at the end of the fiscal year under review increased by ¥15,517 million from the end of the previous fiscal year to ¥158,538 million. This was mainly due to increases of ¥7,005 million in property, plant and equipment, ¥4,155 million in goodwill, and ¥3,949 million in trade and other receivables.」
The goodwill balance increased from ¥58,414 million at the end of the previous fiscal year to ¥62,569 million, further increasing exposure to the risk of unrealized post-acquisition synergies and impairment. - FY2026-H1WorsenedAnnual report
「During the current interim consolidated fiscal period, goodwill in the Health Big Data segment increased by ¥3,404 million in connection with business combinations that were individually and collectively immaterial, among other factors.」
The goodwill balance increased from ¥58,414 million at the end of the previous fiscal year to ¥61,818 million. Exposure to the risk of unrealized post-acquisition synergies and impairment has increased further. - FY2025WorsenedAnnual report
「Goodwill 55,974 58,414」
The goodwill balance increased from ¥55,974 million to ¥58,414 million. Exposure to the risk of unrealized post-acquisition synergies and impairment has increased further. - FY2025-H1WorsenedAnnual report
「During the interim consolidated accounting period, goodwill in the health big data segment increased by ¥2,065 million following business combinations and other transactions that were immaterial individually and in aggregate.」
Goodwill in the Health Big Data segment increased by ¥2,065 million in connection with business combinations, bringing the goodwill balance from ¥55,974 million to ¥58,040 million. Exposure to the risk of unrealized post-acquisition synergies and impairment has increased further. - FY2024WorsenedAnnual report
「Assets at the end of the current consolidated fiscal year increased by ¥23,885 million from the end of the previous consolidated fiscal year to ¥122,452 million. This was mainly due to a ¥10,932 million increase in trade and other receivables accompanying business expansion, as well as a ¥16,150 million increase in goodwill resulting from the acquisition of the shares of 株式会社キャンサースキャン and its conversion into a subsidiary, among other factors.」
The goodwill balance increased from ¥39,824 million to ¥55,974 million, including ¥11,496 million of goodwill recognized in connection with the acquisition of 株式会社キャンサースキャン. Exposure to the risk of unrealized post-acquisition synergies and impairment has increased. - FY2024-Q3WorsenedAnnual report
「During the nine-month period of the current fiscal year, goodwill in the Health Big Data segment increased by ¥5,555 million in connection with business combinations that were individually and collectively immaterial.」
Goodwill in the Health Big Data segment related to acquisitions increased from ¥39,824 million at the end of the previous fiscal year to ¥44,921 million, increasing exposure to the risk of unrealized post-acquisition synergies and impairment. - FY2023WorsenedAnnual report
「The Group has also recognized a substantial amount of goodwill arising from acquisitions. The Group believes that this goodwill appropriately reflects the value of each business and its future earnings capacity resulting from the realization of future synergies through business integration. However, if expected results are not achieved due to changes in the business environment, the competitive landscape or other factors, an impairment loss could arise and affect the Group's results of operations.」
Goodwill related to acquisitions increased from ¥19,169 million in the previous fiscal year to ¥39,824 million, including ¥16,401 million related to the acquisition of RWD. Exposure to the risk of unrealized post-acquisition synergies and impairment has increased. - FY2022RestatedAnnual report
「If expected results are not achieved due to changes in the business environment, the competitive landscape or other factors, an impairment loss could arise and affect the Group's results of operations.」
Describes the possibility of failure to realize acquisition synergies, additional funding requirements and goodwill impairment, as well as impairment of investments generally, including fixed assets. - FY2020First statedAnnual report
「Expected profit growth and synergies may not be realized as anticipated due to changes in the business environment, the competitive landscape or other factors, and unexpected liabilities or additional funding requirements may arise.」
Describes the possibility of failing to achieve expected profits and synergies, requiring additional funding and incurring goodwill impairment in connection with active acquisitions.